Please login to the form below

Not currently logged in
Email:
Password:

Aerospan

This page shows the latest Aerospan news and features for those working in and with pharma, biotech and healthcare.

Mylan raises offer for Meda to $9bn

Mylan raises offer for Meda to $9bn

Also due to launch shortly is Aerospan (flunisolide), an inhaler therapy for asthma - incorporating a spacer to improve drug delivery to the lungs - that Meda has said could achieve sales of

Latest news

  • Meda buys US respiratory firm Acton in $200m deal Meda buys US respiratory firm Acton in $200m deal

    Meda buys US respiratory firm Acton in $200m deal. Swedish pharma firm gains access to asthma treatment Aerospan. ... Meda is paying $125m upfront for Acton, which has been sitting on a US approval for an inhaled corticosteroid product called Aerospan

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Genetic Digital

We help healthcare, pharma & medical device organisations use web and mobile technologies to effectively connect patients and healthcare professionals....

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics